SpyGlass Pharma, Inc.
SGP$842M
Small CapNASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
SGP News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
Bimatoprost Implant System
Cataract
Timolol Maleate Ophthalmic Solution, 0.5%
Cataract
Bimatoprost Implant System (High Dose)
Cataract
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Bimatoprost Implant System | Phase 3 | Cataract | - | - |
Timolol Maleate Ophthalmic Solution, 0.5% | Phase 3 | Cataract | - | - |
Bimatoprost Implant System (High Dose) | Phase 2 | Cataract | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply